Wirk, B. and Lim, J. (2025) “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”, Journal of Hematology [Preprint]. doi:10.14740/jh2046.